BIOPORTO DIAGNOSTICS A/S: Financial statements 2012
CVR: 18645882
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 17,858,000 and a net result of DKK -15,105,000. The profit margin was -84.6%. Equity in the 2012 report amounted to DKK -125,824,000. The company had 20 employees in the financial year.
- Revenue
- DKK 17,858,000
- Gross Profit
- DKK 11,054,000
- Profit/Loss
- DKK -15,105,000
- Equity
- DKK -125,824,000
- Total Assets
- DKK 10,371,000
- Employees
- 20
Official annual report
Keep an eye on BIOPORTO DIAGNOSTICS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BIOPORTO DIAGNOSTICS A/S
BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 29 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.